Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CAMX
Cambiar Aggressive Value ETF
34.6
9
USD
0.00%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.20%
Monthly Change
+0.52%
6 month change
+6.44%
Year Change
+6.44%
Previous Close
34.6
2
Open
34.6
9
Low
34.6
9
High
34.6
9
Volume
3
Markets
US ETFs
CAMX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
LUV
SOUTHWEST AIRLINES CO.
1.744 M
46.000 K
2.639%
STZ
CONSTELLATION BRANDS, INC.
1.722 M
11.000 K
2.606%
CME
CME GROUP INC.
1.698 M
5 900.000
2.569%
ET
ENERGY TRANSFER LP
1.696 M
84.000 K
2.566%
AXP
AMERICAN EXPRESS COMPANY
1.664 M
5 150.000
2.517%
ZG
ZILLOW GROUP, INC.
1.575 M
35.300 K
2.383%
VSNT
Versant Media Group, Inc.
1.326 M
33.001 K
2.007%
CVX
CHEVRON CORPORATION
1.199 M
6 200.000
1.813%
SLB
SLB N.V.
1.138 M
20.000 K
1.721%
1
2
News
Camurus reports Q4 revenue miss, lowers 2026 outlook
FDA accepts Camurus’ resubmission for acromegaly treatment Oclaiz
Camurus Q3 2025 slides: Revenue up 18% but stock dips on lowered guidance
Camurus cuts 2025 revenue forecast as Buvidal sales miss estimates
Camurus Q2 2025 slides reveal 52% revenue surge and key regulatory milestones
Earnings call transcript: Camurus AB Q2 2025 earnings beat expectations
Camurus Q2 2025 slides: Record revenue and profit amid product portfolio expansion
Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs
Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal ® incretins
Camurus Q1 2025 slides: record profitability despite market challenges
Camurus stock falls on 1Q revenue miss